每經AI快訊，人福醫藥（SH 600079，收(shou)盤價：19.35元(yuan)(yuan)）3月29日(ri)發布公(gong)(gong)(gong)(gong)告(gao)稱，截至(zhi)本公(gong)(gong)(gong)(gong)告(gao)披(pi)露之(zhi)日(ri)，人福醫藥及全資(zi)或控(kong)股(gu)子(zi)公(gong)(gong)(gong)(gong)司(si)(si)對(dui)外擔保總額(e)為(wei)(wei)約(yue)(yue)91.55億(yi)元(yuan)(yuan)，占(zhan)公(gong)(gong)(gong)(gong)司(si)(si)最(zui)近一(yi)(yi)期經(jing)審計的(de)(de)凈(jing)資(zi)產約(yue)(yue)170.44億(yi)元(yuan)(yuan)的(de)(de)53.71%，全部為(wei)(wei)對(dui)公(gong)(gong)(gong)(gong)司(si)(si)及下(xia)屬全資(zi)或控(kong)股(gu)子(zi)公(gong)(gong)(gong)(gong)司(si)(si)提供的(de)(de)擔保。其中(zhong)公(gong)(gong)(gong)(gong)司(si)(si)及子(zi)公(gong)(gong)(gong)(gong)司(si)(si)對(dui)下(xia)屬全資(zi)或控(kong)股(gu)子(zi)公(gong)(gong)(gong)(gong)司(si)(si)提供的(de)(de)擔保總額(e)為(wei)(wei)約(yue)(yue)71.01億(yi)元(yuan)(yuan)，占(zhan)公(gong)(gong)(gong)(gong)司(si)(si)最(zui)近一(yi)(yi)期經(jing)審計凈(jing)資(zi)產約(yue)(yue)170.44億(yi)元(yuan)(yuan)的(de)(de)41.66%；子(zi)公(gong)(gong)(gong)(gong)司(si)(si)對(dui)上市公(gong)(gong)(gong)(gong)司(si)(si)的(de)(de)擔保總額(e)為(wei)(wei)20.54億(yi)元(yuan)(yuan)，占(zhan)公(gong)(gong)(gong)(gong)司(si)(si)最(zui)近一(yi)(yi)期經(jing)審計凈(jing)資(zi)產約(yue)(yue)170.44億(yi)元(yuan)(yuan)的(de)(de)12.05%。

2022年1至12月份，人福醫藥的營(ying)業收(shou)入構成為(wei)：醫藥占比(bi)51.4%，醫藥批發及(ji)相關(guan)業占比(bi)47.71%。

人(ren)福醫(yi)藥的董(dong)事長是李杰，男，69歲，學歷背景為本科(ke)；總裁是鄧霞飛，男，61歲，學歷背景為博(bo)士(shi)。

道達號（daoda1997）“個股趨勢”提醒：
1. 人福醫藥近30日內北向資金持股量增加241.14萬股，占流通股比例增加0.16%；
2. 近30日內(nei)無機構對人(ren)福醫(yi)藥進(jin)行調研。

每經頭條（nbdtoutiao）——

(記者 蔡鼎)

免責(ze)聲明：本文內容與(yu)數據僅供參(can)考，不構成投資(zi)建議，使(shi)用前請核實。據此操作，風險自擔。